Commentary: Effects of psilocybin on time perception and temporal control of behavior in humans Read More > May 19, 2016
Prohibited or regulated? LSD psychotherapy and the United States Food and Drug Administration Read More > May 18, 2016
Ethical Considerations for Clinical Research and Off-label Use of Ketamine to Treat Mood Disorders: The Balance between Risks and Benefits Read More > May 17, 2016
Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study Read More > May 17, 2016
“Quite a Profoundly Strange Experience”: An Analysis of the Experiences of Salvia divinorum Users Read More > May 13, 2016
"Quite a Profoundly Strange Experience": An Analysis of the Experiences of Salvia divinorum Users Read More > May 13, 2016
Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression Read More > May 12, 2016
Glutamate and GABA Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine Read More > May 12, 2016
